Correction to: Nature https://doi.org/10.1038/s41586-025-08931-1 Published online 7 May 2025
Following publication of this article, the Protein Data Bank entry originally listed in the article (9BTP, in Fig. 4 caption, Methods, Data Availability, Extended Data Table 2 and Reporting Summary) was updated to a new entry: 9OVJ. Accession codes have been updated throughout the paper and data in Extended Data Table 2, the 9OJV column, have been updated in the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Hauseman, Z.J., Stauffer, F., Beyer, K.S. et al. Author Correction: Targeting the SHOC2–RAS interaction in RAS-mutant cancers. Nature 643, E14 (2025). https://doi.org/10.1038/s41586-025-09309-z
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41586-025-09309-z
This article is cited by
-
A new drug target for NRAS(Q61) mutant-expressing cancers
Nature Reviews Drug Discovery (2025)
